Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1998 1
2000 1
2006 1
2009 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
The following term was not found in PubMed: /
Page 1
Ocular effects of apraclonidine in Horner syndrome.
Morales J, Brown SM, Abdul-Rahim AS, Crosson CE. Morales J, et al. Arch Ophthalmol. 2000 Jul;118(7):951-4. Arch Ophthalmol. 2000. PMID: 10900109
METHODS: The study cohort consisted of 6 patients with Horner syndrome (decreased or absent sympathetic innervation of 1 eye). We instilled 1% apraclonidine into the affected eye, and the changes in IOP and pupil diameter (PD) of both eyes were measured over 4 hours …
METHODS: The study cohort consisted of 6 patients with Horner syndrome (decreased or absent sympathetic innervation of 1 eye). We instilled …
Topical apraclonidine testing discloses pupillary sympathetic denervation in diabetic patients.
Koc F, Kansu T, Kavuncu S, Firat E. Koc F, et al. J Neuroophthalmol. 2006 Mar;26(1):25-9. doi: 10.1097/01.wno.0000204648.79744.71. J Neuroophthalmol. 2006. PMID: 16518162
METHODS: Apraclonidine 0.5% was instilled in the eyes of 50 patients with DM and 30 age-matched and gender-matched subjects without DM (control subjects). Pupil diameters (PD) were measured before and 60 minutes after instillation. The duration of DM and the degree …
METHODS: Apraclonidine 0.5% was instilled in the eyes of 50 patients with DM and 30 age-matched and gender-matched subjects without D …
A pharmacologic pupillary test in the diagnosis of diabetic autonomic neuropathy.
Kwon HJ, Kim HY. Kwon HJ, et al. Korean J Ophthalmol. 2009 Dec;23(4):291-5. doi: 10.3341/kjo.2009.23.4.291. Epub 2009 Dec 4. Korean J Ophthalmol. 2009. PMID: 20046691 Free PMC article.
METHODS: A total of 22 diabetic patients were recruited. Baseline pupillary diameter (PD) and the difference in PD between the test eye and the control eye before and after instillation of apraclonidine and pilocarpine were measured. ...Eleven patients (50%) …
METHODS: A total of 22 diabetic patients were recruited. Baseline pupillary diameter (PD) and the difference in PD between the …
Ultrabiomicroscopic study of the effects of brimonidine, apraclonidine, latanoprost and ibopamine on the chamber angle and ciliary body.
Lo Presti L, Morgese A, Ravot M, Brogliatti B, Boles Carenini B. Lo Presti L, et al. Acta Ophthalmol Scand Suppl. 1998;(227):32-4. doi: 10.1111/j.1600-0420.1998.tb00874.x. Acta Ophthalmol Scand Suppl. 1998. PMID: 9972336
The authors used the Zeiss Humphrey (Mod840, 50 MHz) ultrabiomicroscope to evaluate the changes that Brimonidine, Apraclonidine, Latanoprost and Ibopamine cause in the anterior chamber and on the ciliary body of healthy subjects. ...The study showed the miotic effect of Br …
The authors used the Zeiss Humphrey (Mod840, 50 MHz) ultrabiomicroscope to evaluate the changes that Brimonidine, Apraclonidine, Lata …